Literature DB >> 6132639

Hypotensive and alpha-adrenergic activities of 2-(2,3,6-trichlorophenylimino) and 2-(2,3-dichloro-6-methylphenylimino) imidazolidine, two potent derivatives of clonidine.

A de Jonge, P B Timmermans, P A van Zwieten.   

Abstract

1 alpha-Adrenergic activities (hypotension, bradycardia, sedation) and affinities of clonidine and two newly substituted derivatives, 2-(2,3,6-trichlorophenylimino)imidazolidine (I) and 2-(2,3-dichloro-6-methylphenylimino)imidazolidine (II), were determined in various in vitro and in vitro models.2 In anaesthetized normotensive rats, the intravenous -log doses (mol/kg) of clonidine, compound I and II required to decrease mean arterial pressure by 20% were 7.96, 8.39 and 7.79, respectively, and to reduce heart rate by 20% were 7.85, 8.23 and 7.91, respectively. Comparable potencies were obtained in vagotomized rats. Following vertebral arterial infusion of clonidine, compound I and II into anaesthetized cats, the -log doses for 20% diminution in mean arterial pressure were 8.72, 9.17 and 7.92, respectively.3 In pithed normotensive rats, the intravenous -log doses (mol/kg) of clonidine, compound I and II required to elevate diastolic pressure by 50 mmHg were 7.49, 7.80 and 8.04, respectively, whereas 50% of the maximal inhibition of electrical stimulation-induced tachycardia was obtained at -log doses of 8.20, 8.25 and 8.34, respectively.4 In mice, the intraperitoneal -log doses (mol/kg) needed for a prolongation of the hexobarbitone-induced loss of the righting reflex by 100% were 6.51, 6.55 and 6.60 for clonidine, compound I and II, respectively.5 Compounds I and II displayed a higher affinity for alpha(1)- and alpha(2)-adrenoceptors than clonidine, identified in rat cerebral membranes by [(3)H]-prazosin and [(3)H]-clonidine.6 The results show that 2,3,6-trisubstituted derivatives of clonidine are potent alpha-adrenoceptor stimulants. This new class of congeners may have potential for pronounced hypotensive activity following systemic application. It is not likely that among members of this series, hypotensive potency can be separated from sedative activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132639      PMCID: PMC2044727          DOI: 10.1111/j.1476-5381.1983.tb08808.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Alpha-noradrenergic receptor binding in mammalian brain: differential labeling of agonist and antagonist states.

Authors:  D A Greenberg; D C Prichard; S H Snyder
Journal:  Life Sci       Date:  1976-07-01       Impact factor: 5.037

2.  Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.

Authors:  D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Mol Pharmacol       Date:  1977-05       Impact factor: 4.436

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  A comparison of the behavioural effects of some hypotensive imidazoline derivatives in rats.

Authors:  R Laverty
Journal:  Eur J Pharmacol       Date:  1970-02       Impact factor: 4.432

5.  Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery.

Authors:  R W Sattler; P A van Zwieten
Journal:  Eur J Pharmacol       Date:  1967-10       Impact factor: 4.432

6.  Proceedings: Relationship between activity and structure in derivative of clonidine.

Authors:  A Walland; W Hoefke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  Relationship between activity and structure in derivatives of clonidine.

Authors:  W Hoefke; W Kobinger; A Walland
Journal:  Arzneimittelforschung       Date:  1975-05

8.  A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat.

Authors:  J S Gillespie; A Maclaren; D Pollock
Journal:  Br J Pharmacol       Date:  1970-10       Impact factor: 8.739

9.  Effects of low doses of catecholamine receptor agonists on exploration in mice.

Authors:  U Strömbom
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

10.  Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic alpha-adrenoceptors.

Authors:  I Zebrowska-Lupina; E Przegalinski; M Sloniec; Z Kleinrok
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

View more
  1 in total

1.  Structure and alpha-adrenergic activity of pyrazinimidazolines.

Authors:  R Kaliszan; B Damasiewicz; A Nasal; A Radwańska; H Foks; W Kuźmierkiewicz; D Pancechowska-Ksepko; K Rudnicka; K Wisterowicz; K Ośmiałowski
Journal:  Agents Actions       Date:  1985-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.